Find out what the Life Saving Drugs Program is, how it works, which medicines are covered and who can access them.
Find the forms treating physicians need to apply for medicines for their patients under the LSDP.
See the agenda for the next meeting, how to make a submission, and the outcomes of medicine applications and reviews.
Medicine sponsors can read our procedure guidance and template for applying to list a medicine on the LSDP.
Browse the Life Saving Drugs Program for
Find out how to get medicines through the program and what your responsibilities are.
See how to start patients on LSDP medicines, comply with program requirements, and make any required changes over time.
Find out how to become an LSDP pharmacy, manage LSDP medicines correctly, prevent wastage, and keep us informed.
Read the medicines eligibility criteria and find out how to list a medicine on the LSDP.
Soliris® (eculizumab) available on PBS from 1 March 2022
The program that subsidises Soliris® for patients with a rare condition called paroxysmal nocturnal haemoglobinuria (PNH) is changing. Until now, we have subsidised Soliris® under the Life Saving Drugs Program. From 1 March 2022, this will change to the Pharmaceutical Benefits Scheme (PBS).